English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Results 64 patients with primary neoplasm (63.37 %) and 37 patients with secondary tumor (36.63%). There were 30 patients (29.70%) with benign tumor and 71 patients (70.29%) with malignant tumor. Primary tumor consist of chondroma (13 patients, 12.87 %), osteoma (14 patients, 13.86 %), benign toratoma (one patient, 0.99 %), chondro sarcoma (4 patients, 3.96%), osteo sarcoma (22 patients, 21.78%), soft tissue sarcoma (6 patients, 5.94%), Ewing sarcoma (one patient, 0.99%), rhabdomyosarcoma (3 patients, 2.97 %). Metastatic tumor consist of metastatic breast cancer in 22 patients (21.78%), metastatic malignant teratoma in 2 patients (1.98%), matastatic thyroid cancer in 13 patients (12.87%). In the follow-up four years after the operation, no operative mortality. Hospital mortality in 2 patient (1.98%). Local recurrence in 4 patient (3.96%). Five patients with partial flap necrosis (4.95%). No flail chest complication (0 %). Infection rate after operation 3 patient (2.97%). Average LOS after the operation 7-21 days. Loss of follow-up were 58 patients (57.43%), and 52 patients survive (51.48%).

Chest wall tumor and chest wall reconstruction surgery using Tahalele's method